MTOR and metabolic dysfunction-associated steatotic liver disease: More importantly, NEAT1 plays an important role in a rat model of non-alcoholic fatty liver disease (NAFLD) involving the mammalian target of rapamycin/S6 kinase beta-1 signaling pathway (Wang, 2018).